DKA: SQuID Protocol & Subcutaneous Insulin Management
Diabetic Ketoacidosis, DKA, management involves a careful balance of fluids, electrolytes, and insulin. The SQUID protocol offers a structured approach:
Saline (Fluid Management):
Initial fluid resuscitation for most adult DKA patients involves 1 liter of normal saline over 30 to 60 minutes, or 10-20 mL per kg over one to two hours. Rapid fluid administration is crucial for circulatory collapse, but care is needed for patients with heart or kidney failure. Once blood glucose reaches 200-250 mg per dL, intravenous fluids should be switched to dextrose-containing solutions like D5 half normal saline or D5 normal saline to prevent hypoglycemia while allowing continued insulin therapy.
Potassium (Electrolyte Management):
Despite normal or high serum potassium levels in DKA, total body potassium is depleted. Insulin therapy will shift potassium into cells, potentially causing severe hypokalemia. Potassium replacement is guided by serum levels. If potassium is below 3.3 mEq per L, hold insulin and administer 20-40 mEq per hour until it rises above 3.3. If potassium is between 3.3 and 5.2 mEq per L, add 20-40 mEq of potassium to each liter of intravenous fluid. If potassium is above 5.2 mEq per L, do not administer potassium but recheck levels in two hours. Patients with kidney disease may require adjusted doses.
Insulin (Insulin Therapy):
An initial insulin bolus is generally not recommended as it can worsen hypokalemia and does not significantly accelerate DKA resolution. The standard starting dose for an insulin drip is 0.1 units per kg per hour. If blood glucose does not decrease by 50-75 mg per dL per hour, the insulin drip rate should be increased. When blood glucose reaches 200-250 mg per dL, the insulin drip rate should be decreased to 0.02-0.05 units per kg per hour, and dextrose should be added to the intravenous fluids. The insulin drip should continue until the anion gap closes and bicarbonate levels normalize. Before stopping the insulin drip, long-acting insulin should be administered, and the drip should be discontinued one to two hours later.
Dextrose (Glucose Management):
Dextrose is added to intravenous fluids once blood glucose falls to 200-250 mg per dL. This prevents hypoglycemia while maintaining the insulin drip, which is essential for resolving acidosis.
Additional Considerations:
Bicarbonate therapy is generally not recommended unless the pH is extremely low, such as below 6.9 or 7.0, due to risks like worsening hypokalemia, cerebral edema, and paradoxical cerebrospinal fluid acidosis. Phosphate replacement is not routine but may be considered if levels are very low (below 1 mg per dL) or in patients with specific complications like cardiac dysfunction. Magnesium levels should be checked and replaced if low, as hypomagnesemia can exacerbate hypokalemia.
DKA resolution is indicated by an anion gap less than 12, bicarbonate greater than or equal to 18 mEq per L, blood glucose below 200-250 mg per dL, and the patient tolerating oral intake.
https://rebelem.com/rebel-core-cast-dka-beyond-the-basics-part-1-the-squid-protocol/?utm_source=rss&utm_medium=rss&utm_campaign=rebel-core-cast-dka-beyond-the-basics-part-1-the-squid-protocol
